In another small study of ten children with chronic kidney disease and proteinuria that employed a cross-over design, combination therapy with an ACE inhibitor and an ARB reduced proteinuria to a significantly greater extent than either agent alone [34]. Here, ACE is linked to chronic kidney disease.